Q1 2011

Filed May 16, 2011 · 10-Q · 46 days after period end · 0001193125-11-141244

Q1 2011 · 10-Q

Revenue—

Net Income

-$1.42M

no prior Q1 2010 on file

EPS Diluted

-$0.04

no prior Q1 2010 on file

Operating Income-$1,315,000—

Operating Cash Flow-$1,024,000—

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2011 · filed May 16, 2011 · 46 d after period end

Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR